60 related articles for article (PubMed ID: 20736941)
1. Zinc salts provide a novel, prolonged and rapid inhibition of gastric acid secretion.
Kirchhoff P; Socrates T; Sidani S; Duffy A; Breidthardt T; Grob C; Viehl CT; Beglinger C; Oertli D; Geibel JP
Am J Gastroenterol; 2011 Jan; 106(1):62-70. PubMed ID: 20736941
[TBL] [Abstract][Full Text] [Related]
2. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG
Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects.
Kim HK; Park SH; Cheung DY; Cho YS; Kim JI; Kim SS; Chae HS; Kim JK; Chung IS
J Gastroenterol Hepatol; 2010 Oct; 25(10):1618-25. PubMed ID: 20880169
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
[TBL] [Abstract][Full Text] [Related]
5. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
[TBL] [Abstract][Full Text] [Related]
6. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
8. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Miner PB; Allgood LD; Grender JM
Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
[TBL] [Abstract][Full Text] [Related]
10. Coordinated regulation of gastric chloride secretion with both acid and alkali secretion.
Coskun T; Baumgartner HK; Chu S; Montrose MH
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1147-55. PubMed ID: 12381529
[TBL] [Abstract][Full Text] [Related]
11. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
[TBL] [Abstract][Full Text] [Related]
12. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
13. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
Larson GM; Sullivan HW; Rayford PL
Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
[TBL] [Abstract][Full Text] [Related]
14. Influence of gastric acid secretion blockade and food intake on the bioavailability of a potassium diclofenac suspension in healthy male volunteers.
Poli A; Moreno RA; Ribeiro W; Dias HB; Moreno H; Muscara MN; De Nucci G
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):76-9. PubMed ID: 8929750
[TBL] [Abstract][Full Text] [Related]
15. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
16. Failure of nasogastric omeprazole suspension in pediatric intensive care patients.
Haizlip JA; Lugo RA; Cash JJ; Vernon DD
Pediatr Crit Care Med; 2005 Mar; 6(2):182-7. PubMed ID: 15730606
[TBL] [Abstract][Full Text] [Related]
17. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
19. Effects of intrarectally administered omeprazole paste on gastric fluid pH in healthy adult horses.
Rand C; Stanley SD; Pusterla N
Vet Rec; 2011 Jul; 169(5):126. PubMed ID: 21730031
[No Abstract] [Full Text] [Related]
20. Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion.
Nishida H; Fujimori I; Arikawa Y; Hirase K; Ono K; Nakai K; Inatomi N; Hori Y; Matsukawa J; Fujioka Y; Imanishi A; Fukui H; Itoh F
Bioorg Med Chem; 2017 Jul; 25(13):3447-3460. PubMed ID: 28483454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
